Cancer drug target is promising lead for new TB treatments
2010-11-17
(Press-News.org) A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new drugs against tuberculosis (TB), according to a study published in Microbiology on 17 November.
The human equivalent of this enzyme has been targeted in some cancer treatments as well as in immunosuppressive chemotherapies. Scientists at the University of Birmingham have now shown that inhibiting the same enzyme in M. tuberculosis effectively kills the bacterial cells.
The enzyme called IMPDH is crucial for the survival of both human and bacterial cells. It is involved in the first stage of producing guanine nucleotides –the raw materials needed for DNA synthesis - as well as many other housekeeping processes that keep the cell alive and functioning.
The researchers identified the three genes in M. tuberculosis that encode IMPDH and then screened a library of 16 compounds that were likely to impede its function to some extent. Of the 16 diphenyl urea (DPU) compounds, 3 were able to inhibit IMPDH by more than 90%, killing M. tuberculosis cells.
Project leader Professor Gurdyal Besra explained why IMPDH is a promising target to tackle TB. "IMPDH is essential for cells to proliferate rapidly, which is one of the characteristics of microbial infection as well as human cancers. IMPDH has been used as a target in some anti-cancer drugs, as blocking the enzyme can prevent proliferation of the cell and induce cell death. Our findings show that inhibiting the bacterial version of IMPDH is a strategy that could be exploited for anti-TB drugs," he said. "The DPU compounds we tested have selective activity against Mycobacterium species, meaning that any future drugs based on these would be specific and would not affect human cells."
9 million people are newly diagnosed with TB each year with increasing incidences of multi-drug resistant (MDR)-TB and extensively drug resistant (XDR)-TB. "In the face of growing resistance to current therapies, we desperately need new treatments for TB that are safe and effective," stressed Professor Besra. "We are tapping the potential of a so far unexploited target which could lead to the synthesis of a novel anti-tubercular drug and our findings, so far are extremely encouraging," he said.
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-17
Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.
Scientists in the USA have studied 20 genes that are targeted by existing therapies and found that there are significant changes to these genes in a broad range of patients' tumours, including many for which these drugs are not being used at present. ...
2010-11-17
Researchers have shown that point mutations – mis-spellings in a single letter of genetic code – that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalised medicine in which every patient could have their tumour screened, specific mutations identified, and the appropriate drug chosen to target the mutation and halt the growth of their cancer.
Using mass spectrometry for identifying the genetic make-up of cancer cells, OncoMap can determine the point ...
2010-11-17
Scientists believe they may have found a new target for treating triple negative breast cancer – one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.
Triple negative breast cancer (TNBC) is a cancer that does not express receptors for oestrogen (ER), progesterone (PR) or the human epidermal growth factor (HER2). It tends to be more aggressive, occurs more often in younger women, and is difficult to treat successfully as it lacks the receptors that currently available targeted therapies such as tamoxifen ...
2010-11-17
Washington, D.C. (November 16, 2010) -- For more than 250 years, researchers have known that under certain conditions vapor bubbles can form in fluids moving swiftly over a surface. These bubbles soon collapse with such great force that they can poke holes in steel and damage objects such as ship propellers, turbine blades, nozzles and pump impellers.
Scientists have conducted extensive research for decades to try to understand this phenomenon -- called cavitation. But most experiments to date have been related to open-water objects like ship propellers.
Now a group ...
2010-11-17
Washington, D.C. (November 16, 2010) -- While our direct knowledge of black holes in the universe is limited to what we can observe from thousands or millions of light years away, a team of Chinese physicists has proposed a simple way to design an artificial electromagnetic (EM) black hole in the laboratory.
In the Journal of Applied Physics, Huanyang Chen at Soochow University and colleagues have presented a design of an artificial EM black hole designed using five types of composite isotropic materials, layered so that their transverse magnetic modes capture EM waves ...
2010-11-17
Washington, D.C. (November 16, 2010) -- In a move that holds great significance for the semiconductor industry, a team of researchers has created an alternative to conventional logic gates, demonstrated them in silicon, and dubbed them "chaogates." The researchers present their findings in Chaos, a journal published by the American Institute of Physics.
Simply put, they used chaotic patterns to encode and manipulate inputs to produce a desired output. They selected desired patterns from the infinite variety offered by a chaotic system. A subset of these patterns was ...
2010-11-17
CINCINNATI—Researchers at the University of Cincinnati (UC) have found that fat around the outside of arteries may lead to the development of cardiovascular disease and could be linked to its onset in individuals with diabetes.
David Manka, PhD, a researcher in the division of cardiovascular diseases, and his team found that this fat—known as perivascular adipose tissue—could possibly lead to the formation of fatty buildup inside of arteries and could cause existing buildup to break loose, leading to stroke or heart attack.
These findings are being presented at the ...
2010-11-17
The increase in the legal age of sexual consent from 14 to 16 years in 2008 may not be protecting those at greatest risk, according to researchers who have analyzed British Columbia population-based data and recommend additional strategies to safeguard vulnerable children and teens.
In the first study of its kind in Canada, researchers from the University of British Columbia and Simon Fraser University tested the government's reasons for changing the law. Their findings are published in the current issue the Canadian Journal of Human Sexuality.
According to the study's ...
2010-11-17
Risø Energy Report 9 lists a wide range of energy technologies in the market with low or no emissions of greenhouse gases, describing how several of these will be made commercially available in the next decades.
However, it is not possible to make the world's energy supply CO2-free as cheaply as possible, using only technology development in the current energy systems. There must be room for technological leaps and there is a need for an integrated process to optimise the entire energy system, from energy production, through transformation into energy carriers, to energy ...
2010-11-17
Long-nosed Cape rock elephant-shrews are fond of sticky treats, according to Dr. Petra Wester from the University of Stellenbosch in South Africa. Her investigations show for the first time that the elephant-shrew, Elephantulus edwardii, licks the nectar of the flowers and pollinates the Pagoda lily. Her results are published in Springer's journal, Naturwissenschaften – The Science of Nature.
Dr. Wester studied the behavior of the animals in the northern Cederberg area of South Africa, where Pagoda lily plants, Whiteheadia bifolia (Hyacinthaceae), are found in shady rock ...
LAST 30 PRESS RELEASES:
[Press-News.org] Cancer drug target is promising lead for new TB treatments
